Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Archives of Pathology & Laboratory Medicine|March 7, 2001
The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technologyK Ruzicka, M Veitl, R Thalhammer-Scherrer, et al.
Thrombosis Research|November 30, 1999
Evaluation of the automated coagulation analyzer SYSMEX CA 6000P Quehenberger, S Kapiotis, S Handler, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|September 18, 2009
Foam formation on an Austrian-Hungarian lowland river: reasons, methods and solutionsK Ruzicka, O Gabriel, U Wegricht, et al.
Circulation|July 1, 1997
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complexS Kapiotis, B Jilma, P Quehenberger, et al.
American Journal of Clinical Pathology|September 9, 1999
Evaluation of four automated methods for determination of whole blood cyclosporine concentrationsA Hamwi, M Veitl, G Männer, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|April 29, 2008
Investigative monitoring in the context of detecting anthropogenic impact on an epipotamal riverS Winkler, M Zessner, E Saracevic, et al.
Life Sciences|November 10, 1998
Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formationK Ruzicka, J Wojta, O Artemiou, et al.
Thrombosis Research|October 23, 1997
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathwayK Ruzicka, S Kapiotis, P Quehenberger, et al.
Thrombosis Research|March 15, 2001
A common C-->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activityG Endler, M Exner, C Mannhalter, et al.
Thrombosis Research|November 5, 1997
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settingsK Ruzicka, S Kapiotis, P Quehenberger, et al.
Pageof 1